[EN] IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS [FR] DÉRIVÉS D'IMIDAZO(1,2-A)PYRIDINE UTILISÉS EN TANT QU'INHIBITEURS DE RIPK2
摘要:
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof, and compositions comprising same. Also described are methods of treating the diseases and disorders disclosed herein, with the compounds of Formula (I), and pharmaceutically acceptable salts thereof, and the compositions comprising same.
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
申请人:Saksena K. Anil
公开号:US20070032433A1
公开(公告)日:2007-02-08
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
申请人:Saksena Anil K.
公开号:US20110117057A1
公开(公告)日:2011-05-19
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
DIARYL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITS C VIRUS
申请人:Schering Corporation
公开号:EP1343807B1
公开(公告)日:2009-04-29
BENZOPHENONE, DEREN HERSTELLUNG UND VERWENDUNG ZUR BEKÄMPFUNG VON PFLANZENPATHOGENEN PILZEN
申请人:BASF AKTIENGESELLSCHAFT
公开号:EP1373181A1
公开(公告)日:2004-01-02
ORGANIC COMPOUNDS AND THEIR USES
申请人:NOVARTIS AG
公开号:US20130149281A1
公开(公告)日:2013-06-13
The present application describes a method of treating an HCV-associated disorder by administering to a subject in need thereof a pharmaceutically effective amount of a compound of formula I in combination with an additional HCV-modulating compound.